Grifols reported EUR371.86M in Operating Profit for its fiscal quarter ending in December of 2024.


Operating Profit Change Date
Alaunos Therapeutics USD -755000 395K Dec/2024
GlaxoSmithKline GBP 2.02B 193M Jun/2025
Grifols EUR 371.86M 54.83M Dec/2024
Life Technologies USD -20310000 4.49M Jun/2025